期刊文献+

缺氧对细胞膜ABCA1降解的影响及其机制研究 被引量:4

Hypoxia enhances degradation of plasma membrane ABCA1 via increased calpain activity
下载PDF
导出
摘要 目的探讨缺氧对细胞膜三磷酸腺苷结合盒转运体A1(ABCA1)降解的影响及其与钙蛋白酶的相关机制。方法肝X受体激动剂TO-901317刺激RAW264.7细胞24 h,实时定量聚合酶链反应检测ABCA1 m RNA表达水平。生物素标记法提取细胞膜蛋白,Western blot检测细胞膜ABCA1蛋白水平表达。Western blot检测在放线菌酮存在或不存在条件下,TO-901317干预的RAW264.7细胞经过12 h缺氧(1%氧气O_2)处理后细胞膜ABCA1蛋白水平,Suc-LLVY-氨基虫荧光素法检测缺氧细胞内钙蛋白酶活性。RAW264.7细胞给予钙蛋白酶抑制剂ALLN干预,检测细胞膜ABCA1蛋白表达及钙蛋白酶活性。结果 TO-901317上调ABCA1 mRNA及细胞膜蛋白水平表达。无论放线菌酮存在或不存在情况下,缺氧均能降低细胞膜ABCA1蛋白水平,升高钙蛋白酶活性。钙蛋白酶抑制剂ALLN能部分逆转缺氧诱导细胞膜ABCA1蛋白水平降低。结论缺氧可能通过增加钙蛋白酶活性,从而加速细胞膜ABCA1蛋白降解。 Objective To investigate the effect of hypoxia on the degradation of plasma membrane ATP binding cassette transporter A1(ABCA1) and its calpain-related mechanism. Methods q RT-PCR was used to detect ABCA1 mRNA level in RAW264.7 cells stimulated by liver X receptor agonist TO-901317 for 24 h.Plasma membrane protein was extracted by the biotin labeling method of surface proteins, and membrane ABCA1 protein level was determined by Western blot. Western blot was applied to detect the plasma membrane ABCA1 protein level from TO-901317-treated RAW264.7 cells after 12-h hypoxia(1% O_2) treatment in the presence or absence of Cycloheximide. Furthermore, the calpain activity in the hypoxic cells was assayed by the method of Suc-LLVY-aminoluciferin. Finally, plasma membrane ABCA1 protein and calpain activity were measured in the RAW264.7 cells after intervention with calpain inhibitor ALLN. Results LXR agonist TO-901317 up-regulated ABCA1 m RNA and membrane protein levels. Hypoxia reduced plasma membrane ABCA1 protein in the RAW264.7 cells and increased the calpain activity in the absence or presence of Cycloheximide. Calpain inhibitor ALLN, in part, reversed the decrease of plasma membrane ABCA1 induced by hypoxia. Conclusions Hypoxia might accelerate the degradation of plasma membrane ABCA1 via enhancement of calpain activity.
出处 《中国现代医学杂志》 CAS 北大核心 2017年第3期13-17,共5页 China Journal of Modern Medicine
基金 国家自然科学基金(No:31260250)
关键词 三磷酸腺苷结合盒转运体A1 缺氧 钙蛋白酶 放线菌酮 ATP binding cassette transporter A1 hypoxia calpain Cycloheximide
  • 相关文献

参考文献1

二级参考文献11

  • 1BaigentC, BlackwellL, EmbersonJ, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials[J]. Lancet, 2010, 376(9753):1670–1681.
  • 2CareyVJ, BishopL, LaranjoN, et al. Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control[J]. Am J Cardiol, 2010, 106(6):757–763.
  • 3DelahoyPJ, MaglianoDJ, WebbK, et al. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis[J]. Clin Ther, 2009, 31(2):236–244.
  • 4ChungS, SawyerJK, GebreAK, et al. Adipose tissue ATP binding cassette transporter A1 contributes to high-density lipoprotein biogenesis in vivo[J]. Circulation, 2011, 124(15):1663–1672.
  • 5RubinCS, HirschA, FungC, et al. Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells[J]. J Biol Chem, 1978, 253(20):7570–7578.
  • 6GreenH, MeuthM. An established pre-adipose cell line and its differentiation in culture[J]. Cell, 1974, 3(2):127–133.
  • 7HotamisligilGS. Inflammation and metabolic disorders[J]. Nature, 2006, 444(7121):860–867.
  • 8ZhangY, McGillicuddyFC, HinkleCC, et al. Adipocyte modulation of high-density lipoprotein cholesterol[J]. Circulation, 2010, 121(11):1347–1355.
  • 9叶平.以高密度脂蛋白为靶标的抗动脉粥样硬化治疗策略[J].中华心血管病杂志,2008,36(9):784-785. 被引量:5
  • 10苑聪,吴洁.高密度脂蛋白胆固醇与心血管剩余风险[J].中国动脉硬化杂志,2012,20(11):1045-1050. 被引量:9

共引文献5

同被引文献53

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部